881 related articles for article (PubMed ID: 22445239)
1. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Stettler C; Sangiorgi D; D'Ascenzo F; Kimura T; Briguori C; Sabatè M; Kim HS; De Waha A; Kedhi E; Smits PC; Kaiser C; Sardella G; Marullo A; Kirtane AJ; Leon MB; Stone GW
Lancet; 2012 Apr; 379(9824):1393-402. PubMed ID: 22445239
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Valgimigli M; Frati G; Kedhi E; Smits PC; Kaiser C; Genereux P; Galatius S; Kirtane AJ; Stone GW
J Am Coll Cardiol; 2013 Aug; 62(6):496-504. PubMed ID: 23747778
[TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
[TBL] [Abstract][Full Text] [Related]
5. Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials.
Palmerini T; Kirtane AJ; Serruys PW; Smits PC; Kedhi E; Kereiakes D; Sangiorgi D; Bacchi Reggiani L; Kaiser C; Kim HS; De Waha A; Ribichini F; Stone GW
Circ Cardiovasc Interv; 2012 Jun; 5(3):357-64. PubMed ID: 22668554
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.
Palmerini T; Benedetto U; Biondi-Zoccai G; Della Riva D; Bacchi-Reggiani L; Smits PC; Vlachojannis GJ; Jensen LO; Christiansen EH; Berencsi K; Valgimigli M; Orlandi C; Petrou M; Rapezzi C; Stone GW
J Am Coll Cardiol; 2015 Jun; 65(23):2496-507. PubMed ID: 26065988
[TBL] [Abstract][Full Text] [Related]
8. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
9. Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.
Bangalore S; Amoroso N; Fusaro M; Kumar S; Feit F
Circ Cardiovasc Interv; 2013 Aug; 6(4):378-90. PubMed ID: 23922145
[TBL] [Abstract][Full Text] [Related]
10. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
[TBL] [Abstract][Full Text] [Related]
11. Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds: Evidence From a Network Meta-Analysis of 147 Trials.
Kang SH; Chae IH; Park JJ; Lee HS; Kang DY; Hwang SS; Youn TJ; Kim HS
JACC Cardiovasc Interv; 2016 Jun; 9(12):1203-1212. PubMed ID: 27262860
[TBL] [Abstract][Full Text] [Related]
12. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
[TBL] [Abstract][Full Text] [Related]
13. Stent thrombosis with drug-eluting stents: is the paradigm shifting?
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Genereux P; Branzi A; Stone GW
J Am Coll Cardiol; 2013 Nov; 62(21):1915-1921. PubMed ID: 24036025
[TBL] [Abstract][Full Text] [Related]
14. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE; Martinez EE;
Catheter Cardiovasc Interv; 2009 Nov; 74(5):665-73. PubMed ID: 19670303
[TBL] [Abstract][Full Text] [Related]
15. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis.
Kang SH; Park KW; Kang DY; Lim WH; Park KT; Han JK; Kang HJ; Koo BK; Oh BH; Park YB; Kandzari DE; Cohen DJ; Hwang SS; Kim HS
Eur Heart J; 2014 May; 35(17):1147-58. PubMed ID: 24459196
[TBL] [Abstract][Full Text] [Related]
17. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
[TBL] [Abstract][Full Text] [Related]
18. Stent thrombosis in randomized clinical trials of drug-eluting stents.
Mauri L; Hsieh WH; Massaro JM; Ho KK; D'Agostino R; Cutlip DE
N Engl J Med; 2007 Mar; 356(10):1020-9. PubMed ID: 17296821
[TBL] [Abstract][Full Text] [Related]
19. Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis.
Valgimigli M; Sabaté M; Kaiser C; Brugaletta S; de la Torre Hernandez JM; Galatius S; Cequier A; Eberli F; de Belder A; Serruys PW; Ferrante G
BMJ; 2014 Nov; 349():g6427. PubMed ID: 25378023
[TBL] [Abstract][Full Text] [Related]
20. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents.
Stefanini GG; Kalesan B; Pilgrim T; Räber L; Onuma Y; Silber S; Serruys PW; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2012 Mar; 5(3):301-10. PubMed ID: 22440496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
